Acorda Therapeutics, Inc. (NASDAQ:ACOR)

Top Analyst Upgrades and Downgrades: BankUnited, Caterpillar, CoreLogic, eBay, Ford, Kellogg, Lyft, Microsoft, Oshkosh and More

The futures traded higher Thursday morning as analysts and traders digested a huge wave of third-quarter earnings reports. With the political volatility at home and geopolitical volatility abroad, it probably ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Acorda, Activision, Bloom Energy, Care.com, CBS, Deere, Ferrari and More

Stocks may have staged a strong snapback recovery on Tuesday as many tariffs were delayed by 90 days, but the markets were giving back most or all those gains on ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

Stocks were looking for direction after a softer nonfarm payrolls number was met by the lowest unemployment rate in decades. The 10-year Treasury yield is now up to 3.22% and ...
Read Full Story »

Can Acorda Therapeutics Get Past This FDA Move?

Acorda Therapeutics Inc. (NASDAQ: ACOR) shares dipped on Thursday after the company announced that the U.S. Food and Drug Administration (FDA) would be delaying its Prescription Drug User Fee Act ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alarm.com, Biogen, Blue Apron, Cisco, Lowe’s, Pandora, Waste Management and More

This week has been a wild ride, and stocks were looking for direction based on more inflationary concerns after the import prices were hotter than expected. The bull market is ...
Read Full Story »

Top 10 Biopharma Events Kicking Off 2018

Biotechnology and pharmaceutical companies generally face a fair-to-great amount of risk based on the lengthy vetting process for their drug candidates, should a study come back negative or should a ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Cisco, Dollar General, NetApp, Pandora, P&G, Target and More

Stocks were indicated to open handily higher on Thursday, after several consecutive days of selling pressure. Investors know this bull market is more than eight and a half years old, ...
Read Full Story »

Acorda Therapeutics Gets Crushed After Halting Parkinson’s Trial

Acorda Therapeutics Inc. (NASDAQ: ACOR) saw its shares drop sharply following an update on its Parkinson’s trial. The company paused new enrollment in the long-term safety studies, pending further discussion ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Equifax, Mallinckrodt, Nabors, Qualcomm, Salesforce, Snap and More

Wednesday has one thing in common with Monday and Tuesday of this week, and that is that the major stock indexes are looking for direction with the market still ...
Read Full Story »

Acorda Therapeutics Shares Crushed After Receipt of FDA Refusal Letter

Acorda Therapeutics Inc. (NASDAQ: ACOR) saw its shares get crushed early on Tuesday after the firm received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AIG, Boeing, GameStop, Gilead, Starbucks, CIGNA, Ciena, Ferrari and Many More

Stocks were indicated to open marginally higher on Monday, but all eyes remain on the Federal Open Market Committee (FOMC) ahead of this week's interest rate hike decision. The odds ...
Read Full Story »
thumbs up and down

Top Analyst Upgrades and Downgrades: BBVA, Fossil, P&G, T-Mobile, Under Armour, Universal Display and Many More

Stocks were directionless on Wednesday after another strong day after Fed Chair Janet Yellen sure sounded like a March rate hike may be more possible than the market was betting ...
Read Full Story »
Jon's friends

Is This the Big Turnaround Acorda Needs?

Shares of Acorda Therapeutics Inc. (NASDAQ: ACOR) saw a handy gain in early trading on Thursday after the company reported results from its late-stage Parkinson’s trial. Basically, the company announced Phase ...
Read Full Story »
analysis

Top Analysts Upgrades and Downgrades: Anadarko Petroleum, Bristol-Myers, Comcast, Disney, Merck and More

Despite last week ending on a moderately lower note, the Trump rally rolled on for yet another week of gains for investors. With trading volume expected to dive as we ...
Read Full Story »
tired frustrated unhappy business person

Acorda Slides on Clinical Study Update

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is watching its shares slide on Monday after the company gave an update on a recent clinical study. Essentially, the company announced that its Milestone ...
Read Full Story »